08048035996
Arthritis ACTEMRA 400mg Injection trusted to Canada - Toronto | Phoenix Exim | Global Exporter

1. General Information

ACTEMRA is the brand name for tocilizumab, an IL-6 receptor antagonist. It belongs to the class of biologic immunosuppressive medicines. By reducing IL-6-mediated inflammation, it can help control symptoms and disease activity in certain inflammatory disorders.

ACTEMRA 400 mg/20 mL is intended for administration by intravenous infusion after appropriate dilution and should be administered by qualified healthcare professionals.

2. Product Information

  • Brand: ACTEMRA
  • Active ingredient: Tocilizumab
  • Strength: 400 mg/20 mL
  • Concentration: 20 mg/mL
  • Dosage form: Concentrate for solution for infusion
  • Route: Intravenous infusion
  • Drug class: IL-6 receptor antagonist / monoclonal antibody
  • Prescription status: Prescription medicine
  • Presentation: Single-dose vial

The 400 mg vial contains 400 mg of tocilizumab in 20 mL of concentrate.

3. Uses of ACTEMRA 400 mg Injection

Depending on the approved indication in a particular country, tocilizumab may be prescribed for conditions including:

  • Rheumatoid arthritis (RA)
  • Giant cell arteritis (GCA)
  • Systemic sclerosis-associated interstitial lung disease (SSc-ILD)
  • Systemic juvenile idiopathic arthritis (sJIA)
  • Polyarticular juvenile idiopathic arthritis (pJIA)
  • Cytokine release syndrome (CRS) associated with certain cancer immunotherapies
  • Certain hospitalized adults with severe COVID-19 under specific treatment criteria in jurisdictions where this indication is approved.

Approved uses can differ between countries, so the local prescribing information should always be checked.

4. Benefits of ACTEMRA 400 mg Injection

When appropriately prescribed, ACTEMRA may help:

  • Reduce inflammation associated with excessive IL-6 activity.
  • Improve symptoms and disease control in rheumatoid arthritis.
  • Help reduce inflammatory activity associated with giant cell arteritis.
  • Slow decline in pulmonary function in certain adults with systemic sclerosis-associated interstitial lung disease.
  • Treat cytokine release syndrome caused by certain CAR-T cell therapies.
  • Improve overall disease control when conventional therapies have not provided an adequate response.

The benefits depend on the patient's condition, treatment regimen, and response to therapy.

5. Side Effects of ACTEMRA 400 mg Injection

ACTEMRA can cause side effects, ranging from mild reactions to serious complications. Important risks include serious infections, liver-related abnormalities, changes in blood-cell counts, allergic/infusion reactions, and gastrointestinal perforation in susceptible patients.

Patients receiving ACTEMRA require appropriate medical monitoring during treatment.

6. Common Side Effects

Reported adverse effects can include:

  • Upper respiratory tract infections
  • Headache
  • Increased blood pressure
  • Injection- or infusion-related reactions
  • Abnormal liver enzymes
  • Decreased white blood cell or platelet counts
  • Nasopharyngitis
  • Dizziness in some patients

Not every patient experiences these effects. Serious symptoms such as persistent fever, severe abdominal pain, breathing difficulty, or signs of a severe allergic reaction require urgent medical attention.

7. How to Use ACTEMRA 400 mg Injection

ACTEMRA 400 mg IV concentrate is not intended for self-injection. It must be prepared, diluted and administered by a qualified healthcare professional.

The dose and treatment interval depend on the disease, body weight, age, laboratory results and applicable prescribing information. The IV formulation is administered as an infusion rather than as an IV bolus or push.

Patients should follow the exact schedule prescribed by their treating physician.

8. How ACTEMRA Works

Tocilizumab is a monoclonal antibody that binds to the IL-6 receptor. IL-6 is an important signaling molecule involved in inflammation.

By blocking IL-6 from activating its receptor, tocilizumab reduces IL-6-driven inflammatory signaling. This can decrease inflammation and associated symptoms in diseases where excessive IL-6 activity contributes to the disease process.

9. Safety Advice for ACTEMRA

Important safety considerations include:

  • Serious infections: ACTEMRA can increase the risk of serious infections, including bacterial, viral, fungal and opportunistic infections.
  • Tuberculosis: Appropriate screening for latent TB is recommended according to the applicable prescribing information.
  • Liver function: Liver enzymes should be monitored as recommended by the physician.
  • Blood counts: Neutrophil and platelet counts may require monitoring.
  • Gastrointestinal problems: Patients with risk factors for gastrointestinal perforation require particular caution.
  • Allergic reactions: Infusion or hypersensitivity reactions can occur.
  • Vaccinations: Healthcare professionals should review vaccination status before treatment; certain live vaccines may not be appropriate during therapy.
  • Pregnancy/breastfeeding: Discuss with a healthcare professional before treatment.
  • Drug interactions: Tell the physician about all medicines, biologics and supplements being used.

ACTEMRA should not be used by individuals with a known serious hypersensitivity to the medicine, and treatment decisions should be made by a qualified healthcare professional.

10. Frequently Asked Questions (FAQs)

Q1. What is ACTEMRA 400 mg Injection?
ACTEMRA 400 mg Injection is a tocilizumab-containing biologic medicine supplied as a 400 mg/20 mL concentrate for IV infusion.

Q2. What is the generic name of ACTEMRA?
The active ingredient is tocilizumab.

Q3. Is ACTEMRA 400 mg an antibiotic?
No. It is a monoclonal antibody that modifies inflammatory immune signaling.

Q4. How is ACTEMRA 400 mg administered?
The 400 mg vial is prepared and diluted for intravenous infusion by qualified healthcare professionals.

Q5. Can ACTEMRA be used without a prescription?
No. ACTEMRA is a prescription biologic medicine.

Q6. Can ACTEMRA cause infections?
Yes. It can increase the risk of serious infections, which is why appropriate screening and monitoring are important.

Q7. Is ACTEMRA 400 mg the same as tocilizumab 400 mg?
ACTEMRA is a brand of tocilizumab. Other tocilizumab products may be biosimilars or alternative brands and should be selected according to local regulatory approval and medical advice.

Q8. Can the 400 mg vial be self-administered?
The 400 mg presentation is an IV infusion concentrate and is not intended for self-administration.

11. Substitutes for ACTEMRA 400 mg Injection

Potential alternatives may include other approved tocilizumab products, including biosimilar versions, where authorized by the relevant regulatory authority. Other biologic medicines may also be considered depending on the underlying disease, but they are not automatically interchangeable with ACTEMRA.

Examples of alternatives in the broader tocilizumab category include tocilizumab biosimilars. The appropriate substitute should be selected by a physician or pharmacist based on indication, dosage form, regulatory approval and patient-specific factors.

12. SEO Keywords

  • ACTEMRA 400mg Injection exporter from India
  • Actemra 400mg Injection supplier India
  • Actemra 400mg Injection manufacturer and exporter
  • Tocilizumab 400mg Injection exporter India
  • Tocilizumab 400mg IV infusion supplier
  • Actemra 400mg Injection wholesale supplier
  • Actemra 400mg pharmaceutical exporter
  • Actemra 400mg medicine exporter from Nagpur
  • Tocilizumab Injection exporter from Nagpur India
  • Buy Actemra 400mg Injection from India
  • Actemra 400mg Injection international supplier
  • Actemra 400mg Injection export from India
  • Tocilizumab 400mg wholesale exporter
  • Actemra 400mg Injection supplier USA
  • Actemra 400mg Injection supplier UK
  • Actemra 400mg Injection supplier Australia
  • Actemra 400mg Injection supplier Singapore
  • Actemra 400mg Injection supplier Canada
  • Actemra 400mg Injection supplier South Korea
  • Actemra 400mg Injection supplier UAE
  • Genuine Tocilizumab 400mg Injection supplier
  • Tocilizumab 400mg biologic medicine exporter
  • IL-6 inhibitor Injection exporter India
  • Rheumatoid arthritis medicine exporter India
  • Premium pharmaceutical exporter from Nagpur India
  • Phoenix Exim Actemra 400mg supplier
  • Phoenix Exim Tocilizumab exporter
  • Prescription biologic medicine exporter India
  • Pharmaceutical medicine export supplier India
Aug 21st, 2026 3:55 PM

Keywords